Solving technology problems, one at a time
There is growing interest in the use of intranasally administered insulin for treating symptoms of early alzheimers and for improving memory and cognition in general. An article published in Neurology in 2008 describes the results
Continue readingAn enormous breakthrough. Research by Professor Ruth Itzhaki and her team at the University of Manchester confirms earlier suspicions about the role of the HSV1 virus as a cause of Alzheimer’s disease. As reported in
Continue readingBlocking TGF-β-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology.
A new possible treatment target has been demonstrated by a group of researchers working with transgenic mice that are used to model Alzheimer’s in humans. According to New Scientist:
“Richard Flavell at Yale University and colleagues created transgenic mice predisposed to develop brain plaques, and doubly transgenic mice that also had a gene that blocks TGF-beta, a chemical used by the immune system.”
“The researchers expected the second set to fare worse than the first. But to their surprise, the doubly transgenic mice performed better on various mazes”…
Continue reading